← Back to Search

Other

Coffee for Type 2 Diabetes

N/A
Recruiting
Led By Daniel Lamport, PhD
Research Sponsored by University of Reading
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Formal diagnosis of Type 2 Diabetes for 3 years or more
Age 55-70 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up -4 weeks
Awards & highlights

Study Summary

This trial explores the effects of specialty coffee on cognitive function & blood sugar control in people with diabetes, to reduce risk of cognitive decline & diabetes.

Who is the study for?
This trial is for people aged 55-70 with Type 2 Diabetes who have been diagnosed for at least 3 years. They should currently drink coffee, but no more than 4 cups a day, and not be dependent on insulin or already drinking specialty coffee.Check my eligibility
What is being tested?
The study tests if 'specialty coffee' high in chlorogenic acid (CGA) improves brain function and blood sugar control in Type 2 Diabetics compared to regular coffee. Participants will be split into two groups: one drinks specialty coffee, the other conventional, over an eight-week period after a four-week phase of only conventional coffee.See study design
What are the potential side effects?
Since participants are current coffee drinkers, side effects may be minimal and similar to their usual experiences with caffeine. However, changes in cognitive function or blood sugar levels due to different types of coffees could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Type 2 Diabetes for over 3 years.
Select...
I am between 55 and 70 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and -4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Verbal memory
Secondary outcome measures
Anxiety symptoms
Depression symptoms
Executive Function
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CGA-rich coffee (Speciality coffee)Experimental Treatment1 Intervention
Participants will be provided with a single origin, CGA-rich specialty coffee as graded by the Specialty Coffee Association of America's Q-grading system to brew and consume
Group II: Conventional coffeeActive Control1 Intervention
Participants will be provided with a conventional, low CGA coffee to brew and consume which contains less CGA than the experimental arm.

Find a Location

Who is running the clinical trial?

University of ReadingLead Sponsor
147 Previous Clinical Trials
17,189 Total Patients Enrolled
Daniel Lamport, PhDPrincipal InvestigatorUniversity of Reading
2 Previous Clinical Trials
170 Total Patients Enrolled

Media Library

Specialty Coffee (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05709847 — N/A
Type 2 Diabetes Research Study Groups: Conventional coffee, CGA-rich coffee (Speciality coffee)
Type 2 Diabetes Clinical Trial 2023: Specialty Coffee Highlights & Side Effects. Trial Name: NCT05709847 — N/A
Specialty Coffee (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05709847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial include elderly participants who are over 85 years of age?

"This clinical trial is accepting individuals aged 55 and over, but not exceeding 70 years old."

Answered by AI

How many participants are receiving treatment as part of this investigation?

"Affirmative. According to the information on clinicaltrials.gov, this study published on January 1st 2023 is still recruiting candidates. There are 70 total participants being sought out from one medical site and recent updates have been made on January 24th of that same year."

Answered by AI

Does this research program currently seek new participants?

"According to the information on clinicaltrials.gov, this experiment is currently recruiting for participants. Its inception took place on January 1st 2023 and was most recently revised 24 days after its initial posting."

Answered by AI

Is there the possibility of me joining this investigation?

"This research is recruiting 70 individuals aged between 55 and 70 with type 2 diabetes. In addition to the requirement of age, these participants must have had a formal diagnosis for 3 years or more, be current coffee drinkers consuming no more than 4 cups daily (1 cup equals 8 oz)."

Answered by AI

Who else is applying?

What site did they apply to?
Kaiser Permanente
What portion of applicants met pre-screening criteria?
Met criteria
~26 spots leftby Jan 2025